In one study on autoimmune cholangitis (a PBC subtype), LSEC-targeting, 10 μM SIINFEKL peptide-conjugated NPs were administered intravenously to mice one day prior to OT-1-cell (SIINFEKL-specific CD8+ T-cell) transfer. The gene discussed is CD8A; the disease is primary biliary cholangitis.